ArticleFrontiers in genetics2026
miR-379-5p promotes ovarian granulosa cell apoptosis in primary ovarian insufficiency by targeting KNDC1 and PEG10.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary ovarian insufficiency (POI) is a heterogeneous disorder characterized by premature decline in ovarian function in women of reproductive age, yet its molecular mechanisms remain incompletely elucidated. MicroRNAs (miRNAs), as crucial post-transcriptional regulators, may play a crucial role in the onset and progression of POI. Our research sought to elucidate the regulatory roles and mechanisms of key miRNAs and their target genes in ovarian granulosa cells (GCs) from POI patients. Methods: Based on POI-related mRNA and miRNA microarray datasets obtained from GEO database, we employed bioinformatics methods to identify differentially expressed genes (DEGs) and performed functional enrichment analyses. The interactions between miRNAs and target genes were validated using dual-luciferase reporter assays. In POI cell models, following transfection with miRNA mimics or inhibitors using a lipid-based reagent, we assessed their effects on cell proliferation, apoptosis, and cell cycle progression using CCK-8 assays, flow cytometry, real-time quantitative PCR (qRT-PCR), and Western blotting. Finally, rescue experiments were conducted to further validate the underlying mechanism. Results: This study identified 590 DEGs and 610 differentially expressed miRNAs (DEMs) from microarray datasets, which were primarily enriched in processes including cell cycle regulation, chromosome segregation, and tubulin binding. Notably, miR-379-5p was significantly upregulated in the POI group. Intersection analysis of DEGs and predicted miR-379-5p targets identified two key genes, Kinase Non-catalytic C-lobe Domain Containing 1 (KNDC1) and Paternally Expressed Gene 10 (PEG10). Experimental validation confirmed that miR-379-5p was highly expressed in the POI GCs and directly targeted and suppressed the expression of KNDC1 and PEG10. miR-379-5p mimics reduced cell viability, increased apoptosis, and induced G0/G1 phase arrest. Conversely, miR-379-5p inhibition or KNDC1/PEG10 overexpression reversed these phenotypic changes. Conclusion: This study revealed elevated miR-379-5p expression in POI GCs, which induced cell cycle arrest and apoptosis by suppressing the expression of KNDC1 and PEG10. These findings provide a theoretical basis for understanding POI pathogenesis and for developing targeted therapeutic strategies centered on miR-379-5p.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.